cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution.
Shuo LiWeihua ZengXiaohui NiYonggang ZhouMary L StackpoleZorawar S NoorZuyang YuanAdam NealSanaz MemarzadehEdward B GaronSteven M DubinettWenyuan LiXianghong Jasmine ZhouPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Our results demonstrated that cfTrack can sensitively and specifically monitor the full spectrum of cancer treatment outcomes using exome-wide mutation analysis of cfDNA.